Ubrogepant is a calcitonin gene-related peptide receptor antagonist approved for the acute treatment of migraine with or without aura in adults. The mass balance and metabolism of ubrogepant was evaluated in six healthy male adults administered a single oral d... ...

请注册登录后继续浏览